Literature DB >> 32523955

Kidney Health for Everyone Everywhere - From Prevention to Detection and Equitable Access to Care.

Philip Kam-Tao Li1, Guillermo Garcia-Garcia2, Siu-Fai Lui3, Sharon Andreoli4, Winston Wing-Shing Fung1, Anne Hradsky5, Latha Kumaraswami6, Vassilios Liakopoulos7, Ziyoda Rakhimova5, Gamal Saadi8, Luisa Strani5, Ifeoma Ulasi9, Kamyar Kalantar-Zadeh10.   

Abstract

The global burden of chronic kidney disease (CKD) is rapidly increasing with a projection of becoming the 5th most common cause of years of life lost globally by 2040. Aggravatingly, CKD is a major cause of catastrophic health expenditure. The costs of dialysis and transplantation consume up to 3% of the annual healthcare budget in high-income countries. Crucially, however, the onset and progression of CKD is often preventable. In 2020, the World Kidney Day campaign highlights the importance of preventive interventions - be it primary, secondary or tertiary. This complementing article focuses on outlining and analyzing measures that can be implemented in every country to promote and advance CKD prevention. Primary prevention of kidney disease should focus on the modification of risk factors and addressing structural abnormalities of the kidney and urinary tracts, as well as exposure to environmental risk factors and nephrotoxins. In persons with pre-existing kidney disease, secondary prevention, including blood pressure optimization and glycemic control, should be the main goal of education and clinical interventions. In patients with advanced CKD, management of co-morbidities such as uremia and cardiovascular disease is a highly recommended preventative intervention to avoid or delay dialysis or kidney transplantation. Political efforts are needed to proliferate the preventive approach. While national policies and strategies for non-communicable diseases might be present in a country, specific policies directed toward education and awareness about CKD screening, management and treatment are often lacking. Hence, there is an urgent need to increase the awareness of the importance of preventive measures throughout populations, professionals and policy makers.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Awareness; Detection; Kidney diseases; Prevention

Year:  2020        PMID: 32523955      PMCID: PMC7265722          DOI: 10.1159/000506528

Source DB:  PubMed          Journal:  Kidney Dis (Basel)        ISSN: 2296-9357


  36 in total

1.  Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care.

Authors:  Jacobien C Verhave; Stéphan Troyanov; Frédéric Mongeau; Lorraine Fradette; Josée Bouchard; Philip Awadalla; François Madore
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

Review 2.  Reducing major risk factors for chronic kidney disease.

Authors:  Valerie A Luyckx; Katherine R Tuttle; Guillermo Garcia-Garcia; Mohammed Benghanem Gharbi; Hiddo J L Heerspink; David W Johnson; Zhi-Hong Liu; Ziad A Massy; Orson Moe; Robert G Nelson; Laura Sola; David C Wheeler; Sarah L White
Journal:  Kidney Int Suppl (2011)       Date:  2017-09-20

Review 3.  Nutritional Management of Chronic Kidney Disease.

Authors:  Kamyar Kalantar-Zadeh; Denis Fouque
Journal:  N Engl J Med       Date:  2017-11-02       Impact factor: 91.245

4.  Analysis from the EMPA-REG OUTCOME® trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics.

Authors:  Gert J Mayer; Christoph Wanner; Matthew R Weir; Silvio E Inzucchi; Audrey Koitka-Weber; Stefan Hantel; Maximilian von Eynatten; Bernard Zinman; David Z I Cherney
Journal:  Kidney Int       Date:  2019-03-21       Impact factor: 10.612

Review 5.  Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline.

Authors:  Howard A Fink; Areef Ishani; Brent C Taylor; Nancy L Greer; Roderick MacDonald; Dominic Rossini; Sameea Sadiq; Srilakshmi Lankireddy; Robert L Kane; Timothy J Wilt
Journal:  Ann Intern Med       Date:  2012-04-17       Impact factor: 25.391

6.  The primary care perspective on routine urine dipstick screening to identify patients with albuminuria.

Authors:  Lipika Samal; Jeffrey A Linder
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-23       Impact factor: 8.237

7.  Relatives in silent kidney disease screening (RISKS) study: A Chinese cohort study.

Authors:  Philip Kam-Tao Li; Jack Kit-Chung Ng; Yuk Lun Cheng; Tze Hoi Kwan; Chi Bon Leung; Miu Fong Lau; Koon Shing Choi; Samuel Ka-Shun Fung; Yiu Wing Ho; Siu Ka Mak; Sydney Chi-Wai Tang; Kin Shing Wong; David Yong; Sing Leung Lui
Journal:  Nephrology (Carlton)       Date:  2017-12       Impact factor: 2.506

8.  Public lacks knowledge on chronic kidney disease: telephone survey.

Authors:  K M Chow; C C Szeto; Bonnie C H Kwan; C B Leung; Philip K T Li
Journal:  Hong Kong Med J       Date:  2014-03-14       Impact factor: 2.227

Review 9.  Current Management of Patients With Acquired Solitary Kidney.

Authors:  Ekamol Tantisattamo; Donald C Dafoe; Uttam G Reddy; Hirohito Ichii; Connie M Rhee; Elani Streja; Jaime Landman; Kamyar Kalantar-Zadeh
Journal:  Kidney Int Rep       Date:  2019-07-11

10.  Rationale and population-based prospective cohort protocol for the disadvantaged populations at risk of decline in eGFR (CO-DEGREE).

Authors:  Ben Caplin; Neil Pearce; Marvin Gonzalez-Quiroz; Dorothea Nitsch; Sophie Hamilton; Cristina O'Callaghan Gordo; Rajiv Saran; Jason Glaser; Ricardo Correa-Rotter; Kristina Jakobsson; Ajay Singh; Nalika Gunawardena; Adeera Levin; Giuseppe Remuzzi
Journal:  BMJ Open       Date:  2019-09-24       Impact factor: 2.692

View more
  1 in total

Review 1.  Ferric citrate for the treatment of hyperphosphatemia and anemia in patients with chronic kidney disease: a meta-analysis of randomized clinical trials.

Authors:  Li Li; Xin Zheng; Jin Deng; Junlin Zhou; Jihong Ou; Tao Hong
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.